[
    [
        {
            "time": "",
            "original_text": "中国首个自主研发的门冬胰岛素30注射液生产在即 甘李药业加速国产替代",
            "features": {
                "keywords": [
                    "门冬胰岛素",
                    "自主研发",
                    "甘李药业",
                    "国产替代"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "中国首个自主研发的门冬胰岛素30注射液生产在即 甘李药业加速国产替代",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股普遍调整，泰格医药、甘李药业、凯莱英、金域医学领跌",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "调整",
                    "泰格医药",
                    "甘李药业",
                    "凯莱英",
                    "金域医学",
                    "领跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍调整，泰格医药、甘李药业、凯莱英、金域医学领跌",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]